CanAfrica Holdings acquired Pharmaceutical Development Company (Pty) Ltd from Corix Bioscience, Inc. (OTCPK:CXBS) for CAD 7 million on May 23, 2018. The purchase price is being paid as CAD 1.3 million in cash and CAD 5.7 million in public shares of Kaneh Bosm Biotechnology, Inc. Paesano Akkashian Apkarian P.C. acted as legal advisor for Corix Bioscience. CanAfrica Holdings completed the acquisition of Pharmaceutical Development Company (Pty) Ltd from Corix Bioscience, Inc. (OTCPK:CXBS) on May 23, 2018. The cash portion of consideration was paid on closing and shares consideration will be transferred to Corix Bioscience at a later date.